Patient with localized lesions such as pulmonary nodules on chest x-ray, CT or PET CT
Histopathologic examination is necessary if lung lesion is unknown
Histologic findings affect the disease stage or treatment plan
If the investigator decides to perform a percutaneous lung biopsy because the biopsy or diagnosis through the bronchoscopy is not possible or has low risk-benefit
Patient who have consented to contraception during the period of clinical trial participation (one month after the procedure)
Patient who voluntarily agree to participate in this clinical trial and are willing to comply with the protocol
You may not be if
Patient with pulmonary function insufficiency
Patient who has difficulty in self-breathing (e.g, breathing through oxygen breathing apparatus)
Patient with Uncontrolled coagulation disorders (INR \> 1.3 or Blood platelet count \< 50,000/µl)